These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20179592)

  • 1. Noninvasive tools to assess liver disease.
    Patel K
    Curr Opin Gastroenterol; 2010 May; 26(3):227-33. PubMed ID: 20179592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of fibrosis markers.
    Patel K; Shackel NA
    Curr Opin Gastroenterol; 2014 May; 30(3):253-9. PubMed ID: 24671009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
    Moreno S; García-Samaniego J; Moreno A; Ortega E; Pineda JA; del Romero J; Tural C; von Wichmann MA; Berenguer J; Castro A; Espacio R
    J Viral Hepat; 2009 Apr; 16(4):249-58. PubMed ID: 19215579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive tools to assess liver disease.
    Clark PJ; Patel K
    Curr Opin Gastroenterol; 2011 May; 27(3):210-6. PubMed ID: 21248634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic approaches in the search for biomarkers of liver fibrosis.
    Cowan ML; Rahman TM; Krishna S
    Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease.
    Adams LA; Angulo P
    Clin Liver Dis; 2007 Feb; 11(1):25-35, viii. PubMed ID: 17544970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical and histopathologic perspective on evolving noninvasive and invasive alternatives for liver biopsy.
    Van Leeuwen DJ; Balabaud C; Crawford JM; Bioulac-Sage P; Dhillon AP
    Clin Gastroenterol Hepatol; 2008 May; 6(5):491-6. PubMed ID: 18455694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive monitoring of patients with chronic hepatitis C.
    Fontana RJ; Lok AS
    Hepatology; 2002 Nov; 36(5 Suppl 1):S57-64. PubMed ID: 12407577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FibroMAX: towards a new universal biomarker of liver disease?
    Morra R; Munteanu M; Imbert-Bismut F; Messous D; Ratziu V; Poynard T
    Expert Rev Mol Diagn; 2007 Sep; 7(5):481-90. PubMed ID: 17892356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.